Clinical trial Recruiting at 1 site Observational

Understanding the causes and treatments of recurrent acute pancreatitis

Official title: Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis: a Prospective Cohort Study

Run by Changhai Hospital · NCT06355206 · Data updated 2026-11-12

This study is trying to find out what causes recurrent acute pancreatitis and whether treatments like endoscopy, surgery, or conservative care can help prevent it from coming back.

More Acute Pancreatitis trials

Quick facts

Study typeObservational
SexAll
Enrollment2000 (estimated)
SponsorChanghai Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 22, 2024
Main results expectedDecember 2034
Study endsDecember 2034
Registry record updatedMay 9, 2024
Trial IDNCT06355206 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with recurrent acute pancreatitis.

Probably not a fit

Patients who are unwilling or unable to provide consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to investigate the etiology, natural progression, and therapeutic effects of recurrent acute pancreatitis (RAP). It will assess whether endoscopic intervention, surgery, or conservative treatment can reduce the recurrence of acute pancreatitis and identify risk factors associated with its recurrence. Patients will be closely monitored, and their clinical information will be systematically recorded to provide insights into the condition's management and outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from recurrent acute pancreatitis.

How similar studies have gone: While there have been studies on acute pancreatitis, this specific observational approach focusing on recurrent cases and treatment efficacy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with recurrent acute pancreatitis.

Exclusion Criteria:

* Unwilling or unable to provide consent.

Where it's running

  • Changhai Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.